Utilizing a new self-centering hysteresis model to assess the seismic vulnerability of a long-span cable-stayed bridge equipped with SMA wire-based roller bearings

por Li, Shuai, Farshad, Hedayati Dezfuli, Wang, Jing Quan, Alam, M. Shahria
Publicado 2022

Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19

por Shen, Wei-Xi, Luo, Rong-Cheng, Wang, Jing-Quan, Chen, Zhe-Sheng
Publicado 2021

Overexpression of ABCC1 Confers Drug Resistance to Betulin

por Chen, Xuan-Yu, Yang, Yuqi, Wang, Jing-Quan, Wu, Zhuo-Xun, Li, Jing, Chen, Zhe-Sheng
Publicado 2021

Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment

por Zou, Houwen, Yang, Yuqi, Dai, Huiqiang, Xiong, Yunchuang, Wang, Jing-Quan, Lin, Lusheng, Chen, Zhe-Sheng
Publicado 2021

Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR

por Bin Kanner, Yuval, Teng, Qiu-Xu, Ganoth, Assaf, Peer, Dan, Wang, Jing-Quan, Chen, Zhe-Sheng, Tsfadia, Yossi
Publicado 2023

The Multidrug Resistance-Reversing Activity of a Novel Antimicrobial Peptide

por Teng, Qiu-Xu, Luo, Xiaofang, Lei, Zi-Ning, Wang, Jing-Quan, Wurpel, John, Qin, Zuodong, Yang, Dong-Hua
Publicado 2020

The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells

por Gao, Hai-Ling, Cui, Qingbin, Wang, Jing-Quan, Ashby, Charles R., Chen, Yanchun, Shen, Zhi-Xin, Chen, Zhe-Sheng
Publicado 2023

Insights on the structure–function relationship of human multidrug resistance protein 7 (MRP7/ABCC10) from molecular dynamics simulations and docking studies

por Wang, Jing‐Quan, Cui, Qingbin, Lei, Zi‐Ning, Teng, Qiu‐Xu, Ji, Ning, Lin, Lusheng, Liu, Zhijun, Chen, Zhe‐Sheng
Publicado 2021

Establishment and Characterization of a Novel Multidrug Resistant Human Ovarian Cancer Cell Line With Heterogenous MRP7 Overexpression

por Wang, Jing-Quan, Wu, Zhuo-Xun, Yang, Yuqi, Li, Jin-Sui, Yang, Dong-Hua, Fan, Ying-Fang, Chen, Zhe-Sheng
Publicado 2021

Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells

por Zhang, Lei, Ye, Biwei, Lin, Yunfeng, Li, Yi-Dong, Wang, Jing-Quan, Chen, Zhuo, Ping, Feng-Feng, Chen, Zhe-Sheng
Publicado 2022

Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor

por Wu, Zhuo-Xun, Yang, Yuqi, Wang, Jing-Quan, Narayanan, Silpa, Lei, Zi-Ning, Teng, Qiu-Xu, Zeng, Leli, Chen, Zhe-Sheng
Publicado 2021

Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells

por Zhang, Yongchao, Wu, Zhuo-Xun, Yang, Yuqi, Wang, Jing-Quan, Li, Jun, Sun, Zoey, Teng, Qiu-Xu, Ashby, Charles R., Yang, Dong-Hua
Publicado 2020

The Spleen Tyrosine Kinase Inhibitor, Entospletinib (GS-9973) Restores Chemosensitivity in Lung Cancer Cells by Modulating ABCG2-mediated Multidrug Resistance

por Narayanan, Silpa, Wu, Zhuo-Xun, Wang, Jing-Quan, Ma, Hansu, Acharekar, Nikita, Koya, Jagadish, Yoganathan, Sabesan, Fang, Shuo, Chen, Zhe-Sheng, Pan, Yihang
Publicado 2021

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells

por Zhang, Wei, Fan, Ying-Fang, Cai, Chao-Yun, Wang, Jing-Quan, Teng, Qiu-Xu, Lei, Zi-Ning, Zeng, Leli, Gupta, Pranav, Chen, Zhe-Sheng
Publicado 2018

Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells

por Cui, Qingbin, Cai, Chao-Yun, Wang, Jing-Quan, Zhang, Shuang, Gupta, Pranav, Ji, Ning, Yang, Yuqi, Dong, Xingduo, Yang, Dong-Hua, Chen, Zhe-Sheng
Publicado 2019

Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer Cells

por Wu, Zhuo-Xun, Yang, Yuqi, Wang, Jing-Quan, Zhou, Wen-Min, Chen, Junyu, Fu, Yi-Ge, Patel, Ketankumar, Chen, Zhe-Sheng, Zhang, Jian-Ye
Publicado 2021

The Novel benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 Transporter

por Narayanan, Silpa, Gujarati, Nehaben A., Wang, Jing-Quan, Wu, Zhuo-Xun, Koya, Jagadish, Cui, Qingbin, Korlipara, Vijaya L., Ashby, Charles R., Chen, Zhe-Sheng
Publicado 2021

PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study

por Yang, Yuqi, Teng, Qiu-Xu, Wu, Zhuo-Xun, Wang, Jing-Quan, Lei, Zi-Ning, Lusvarghi, Sabrina, Ambudkar, Suresh V., Ji, Ning, Chen, Zhe-Sheng
Publicado 2022

MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter: In vitro and in vivo study

por Wu, Zhuo-Xun, Teng, Qiu-Xu, Yang, Yuqi, Acharekar, Nikita, Wang, Jing-Quan, He, Min, Yoganathan, Sabesan, Lin, Jun, Wang, Jian, Chen, Zhe-Sheng
Publicado 2022

Dual TTK/CLK2 inhibitor, CC‐671, selectively antagonizes ABCG2‐mediated multidrug resistance in lung cancer cells

por Wu, Zhuo‐Xun, Yang, Yuqi, Wang, Guangsuo, Wang, Jing‐Quan, Teng, Qiu‐Xu, Sun, Lingling, Lei, Zi‐Ning, Lin, Lizhu, Chen, Zhe‐Sheng, Zou, Chang
Publicado 2020